| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chf Medical and Innovation Ofr | Chief Innovation Officer | Chief Science Officer
1 company
Weinberg Uri is a Chf Medical and Innovation Ofr at NVCR. Recent filings cover 0 purchases and 16 sales. Those positions are worth an estimated $3.6M at current prices.
Our model assigns Weinberg Uri a strong insider score of 72/100, based on 5 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +50.5%.
Weinberg Uri's largest disclosed position is in NVCR as Chf Medical and Innovation Ofr, worth about $3.6M. The recent filings there lean toward selling, a net 61,485 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | NVCR Novocure Limited | Chf Medical and Innovation Ofr | Sell | 6,412 | $13.31 | $85,314.22 | -2.3% | +17.9% | - | |
| Mar 2, 2026 | NVCR Novocure Limited | Chf Medical and Innovation Ofr | Sell | 10,733 | $13.68 | $146,863.44 | -4.6% | +22.6% | - | |
| Mar 3, 2025 | NVCR Novocure Ltd | Chief Innovation Officer | Sell | 268 | $18.92 | $5,071.02 | -0.2% | -7.4% | -27.8% | |
| Feb 28, 2025 | NVCR Novocure Ltd | Chief Innovation Officer | Sell | 4,637 | $18.75 | $86,949.24 | -2.7% | +1.7% | -28.4% | |
| Jan 5, 2023 | NVCR Novocure Ltd | Chief Science Officer | Sale+OE | 8,143 | $116.14 | $945,756.00 | -15.8% | -47.7% | -88.8% | |
| May 10, 2021 | NVCR Novocure Ltd | Chief Science Officer | Sale+OE | 5,650 | $189.65 | $1,071,522.50 | -15.1% | -18.5% | -66.2% | |
| Mar 23, 2021 | NVCR Novocure Ltd | Chief Science Officer | Sale+OE | 3,892 | $140.00 | $544,880.00 | -9.7% | +58.5% | -41.4% | |
| Feb 22, 2021 | NVCR Novocure Ltd | Chief Science Officer | Sale+OE | 6,500 | $175.50 | $1,140,750.00 | -19.1% | - | - | |
| Sep 25, 2020 | NVCR Novocure Ltd | Chief Science Officer | Sale+OE | 15,250 | $103.35 | $1,576,087.50 | -35.6% | - | - |